Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Businessweek Archives

A Laser Facelift For Equimed

Inside Wall Street


Cosmetic laser surgery, anyone? EquiMed (EQMD) expects to be able to provide such a service this year. Within a week, the company expects to sign an agreement, says one investment manager, with Palomar Medical Technologies to establish laser centers at all EquiMed clinics.

EquiMed owns or operates 30 radiation oncology therapy centers and 18 ophthalmology clinics in 16 states. These include seven ambulatory surgical units.

Palomar makes lasers, used mainly for burns, cosmetic dermatology, and hair removal. Palomar's EpiLaser won a Food & Drug Administration O.K. in July for dermatological applications.

By next year, EquiMed and Palomar expect to have set up 50 to 60 laser centers around the country. Each center, estimates one analyst, could bring in yearly revenues of $2 million, for a total of $100 million. EquiMed and Palomar will split sales and earnings equally.

Analyst Craig Dickson of Everen Securities projects that, even before any contribution from laser centers, EquiMed will earn 45 cents this year and 85 cents next, vs. 31 cents in 1995. Now at 7, EquiMed is worth 20, figures Dickson.By GENE G. MARCIALReturn to top

Return to top

blog comments powered by Disqus